| ¿µ¹® | multiple sclerosis | ÇÑ±Û | ´Ù¹ß°æÈÁõ |
|---|---|---|---|
| ¼³¸í | ½Å°æÃà»èÀ» µÑ·¯½Î°í ÀÖ´Â ¸»ÀÌÁý(myelin sheath)ÀÇ ÆÄ±«·Î ÀÎÇÑ º´Àû»óŸ¦ ¸»ÇÔ. ÆÄ±«µÈ ¸»ÀÌÁýÀº ÈäÅ͸¦ ³²±â°Ô µÇ¾î ½Å°æÃà»èÀ» ÅëÇÑ ½Å°æÀü´ÞÀÌ Á¦´ë·Î µÇÁö ¾Ê¾Æ ¿îµ¿, °¨°¢, ÀÚÀ²½Å°æ ¸ðµÎÀÇ ½Å°æÀü´ÞÀå¾Ö°¡ ³ªÅ¸³´Ù. ÀÌ º´ÅÍ´Â ¾îµð¼³ª ³ªÅ¸³¯ ¼ö ÀÖ¾î¼ ±× Àå¾Ö°¡ ³ªÅ¸³ª´Â ºÎÀ§¿¡ µû¶ó ¼·Î ´Ù¸¥ Áõ»óÀ» È£¼ÒÇÑ´Ù. |
||
| ¿µ¹® | multiple myeloma | ÇÑ±Û | ´Ù¹ß°ñ¼öÁ¾ |
|---|---|---|---|
| ¼³¸í | ´Ù¹ß¼º ¿ø¹ß¼º°ñÁ¾¾ç. ¸Ó¸®»À-°¥ºñ»À-º¹Àå»À-ôÃß»À-°ñ¹Ý µî¿¡ Àß ³ªÅ¸³ª°í, ¹°··¹°··ÇÑ Á¾±«¸¦ Çü¼ºÇϸç, »ÀÀÇ Èí¼ö°¡ ÀϾ°í, 40~60¼¼ ³²ÀÚ¿¡°Ô ¸¹ÀÌ ¹ß»ýÇÑ´Ù. °ñ¼öÁ¾ Á¾¾ç¼¼Æ÷´Â ÇüÁú¼¼Æ÷¿¡¼ À¯·¡ÇÑ °ÍÀÌ¾î¼ ÇüÁú¼¼Æ÷Á¾À̶ó°íµµ ÇÑ´Ù. °ú°Å¿¡´Â ÇüÁú¼¼Æ÷¼º°ñ¼öÁ¾ À̿ܿ¡´Â ´Ù¸¥ °ñ¼öÁ¶Ç÷¿ä¼Ò¿¡¼ »ý±â´Â °ñ¼öÁ¾À̶ó°í »ý°¢ÇßÁö¸¸ ÇöÀç´Â ºÎÁ¤µÇ°í ÀÖ´Ù. ÇüÁú¼¼Æ÷´Â ¿ø·¡ ¸é¿ª±Û·ÎºÒ¸°À» »ý»êÇÏ´Â ¼¼Æ÷À̸ç, ±×°ÍÀÌ Á¾¾çÈÇÑ ´Ù¹ß °ñ¼öÁ¾ ȯÀÚ¿¡¼µµ ´ëºÎºÐ Ç÷û ¼Ó¿¡ ¸é¿ª ±Û·ÎºÒ¸°ÀÌ Áõ°¡µÈ °ÍÀ» º¼ ¼ö ÀÖ´Ù. Áõ°¡ÇÑ ±Û·ÎºÒ¸°Àº IgG³ª IgAÀÎ °æ¿ì°¡ ¸¹Áö¸¸ ´Ù¸¥ Çüµµ ÀÖ´Ù. °ñ¼öÁ¾ ȯÀÚ ¾à 50%´Â ¿ÀÁÜ¿¡¼ º¥½ºÁÔ½º´Ü¹éÁúÀÌ °ËÃâµÇ´Âµ¥, ÀÌ ´Ü¹éÁúÀÇ ÃàÀû¿¡ ÀÇÇØ ¿ä¼¼°üÀÌ ÆÄ±«µÇ°í, ÄáÆÏ°æÈ°¡ ÀϾÙ. °ñ¼öÁ¾ ȯÀÚ¿¡¼´Â Ç÷û´Ü¹é ÀÌ»óÀ¸·Î °¡²û ¾Æ¹Ð·ÎÀ̵åÁõÀÌ ³ªÅ¸³´Ù. »À X¼± ¼Ò°ßÀ¸·Î¼´Â µµ·Á³½ º´ÅÍ, °ñÀ¶ÇØ»ó, º´Àû°ñÀýÀÌ °üÂûµÈ´Ù. |
||
| ¿µ¹® | multiple personality | ÇÑ±Û | ´ÙÀμº ÀÎ°Ý |
|---|---|---|---|
| ¼³¸í | ÇØ¸®¼º Á¤½ÅÀå¾ÖÀÇ Çϳª·Î ³ªÅ¸³´Ù. ÇÑ »ç¶÷ÀÌ ¿©·¯ »ç¶÷ÀÇ ¼º°ÝÀ» ¼ÒÀ¯Çϰí ÀÖ´Â °ÍÀ¸·Î ¸¶Ä¡ ¡°Áöų¹Ú»ç¿Í ÇÏÀÌµå ¾¾¡±¿Í °°Àº °æ¿ìÀÌ´Ù. ¾Æ¸¶, ÇöÀç ÀÚ½ÅÀÇ Ã³Áö¿¡¼ ¹þ¾î³ª°í ½ÍÀº ¹«ÀǽÄÀûÀÎ ¿å¸Á¿¡¼ ºñ·ÔµÇ´Â °ÍÀ¸·Î ¿©°ÜÁø´Ù. |
||
| ¿µ¹® | pregnancy | ÇÑ±Û | ÀӽŠ|
|---|---|---|---|
| ¼³¸í | Á¤ÀÚ¿Í ³ÀÚ°¡ ¼öÁ¤µÇ¾î »ý±ä ¹è¾Æ ȤÀº žƸ¦ ¿©ÀÚÀÇ Ã¼³»¿¡ Áö´Ï°í ÀÖ´Â »óÅ·ΠÀ̵éÀº Ãâ»ê Àü±îÁö °è¼Ó ¹ß´Þ°ú ¼ºÀåÀ» ÇÑ´Ù. |
||
| ¿µ¹® | toxemia of pregnancy | ÇÑ±Û | ÀÓ½ÅÁßµ¶Áõ |
|---|---|---|---|
| ¼³¸í | ÀÓ»êºÎ¿¡¼ ³ªÅ¸³ª´Â Ç÷°ü °úÀ×¹ÝÀÀ¼ºÀ¸·Î ÀÎÇÑ ÀϱºÀÇ Áõ»ó. °íÇ÷¾Ð, ´Ü¹é´¢, üÁßÁõ°¡¸¦ µ¿¹ÝÇÑ Àü½ÅÀû ºÎÁ¾ÀÌ 3´ë ÁÖÁõ»óÀÌ¸ç ½ÉÇÑ °æ¿ì °£Áú ¹ßÀÛÀ» º¸À̱⵵ ÇÑ´Ù. ÃÊ»êºÎ, ½ÖÅÂ¾Æ ÀӽŠµî¿¡¼ ÀÚÁÖ ³ªÅ¸³ª¸ç, ½ÉÇÑ °æ¿ì »ê¸ð¿Í ÅÂ¾Æ ¸ðµÎ À§ÇèÇÒ ¼ö ÀÖ´Ù. ±×¸®°í, ½ÉÇÑ °íÇ÷¾Ð°ú °£Áú ¹ßÀÛÀ¸·Î ÀÎÇÑ Å¾ÆÀÇ »ê¼Ò ºÎÁ·À» ¹æÁöÇϱâ À§ÇØ ±ä¹ÐÇÑ °¨½Ã¸¦ ¿äÇÑ´Ù. |
||
| HN | head and neck; head nurse; hemagglutinin neuraminidase; hematemesis neonatorum; hemorrhage of newbor... |
|---|---|
| MEN | Multiple Endocrine Neoplasia ; AD Trait 1. MEN Type I(= Wermer Syndro... |
| ABC | absolute basophil count; absolute bone conduction; acalculous biliary colic; acid balance control; a... |
| PT | pain threshold; parathormone; parathyroid; paroxysmal tachycardia; part time; patient; pericardial t... |
| LBWI | Low Birth Weight Infant; ÀúÃâ»ýüÁß¾Æ(î¸õóßæô÷ñìä®) ¿øÀÎ 1. ¸ðü;Mother &nbs... |
| hyaline membrane disease of the newborn | A disease seen especially in premature neonates with respiratory distress; characterised postmortem by atelectasis and alveolar ducts lined by an eosinophilic membrane; also associated with reduced amounts of lung surfactant. Synonym: hyaline membrane syndrome, respiratory distress syndrome of the newborn. (05 Mar 2000) |
|---|---|
| spontaneous gangrene of newborn | Gangrene due to vascular occlusion of unknown cause, usually in marasmic or dehydrated infants. (05 Mar 2000) |
| newborn | neonatal, neonate |
| newborn jaundice | <paediatrics> A normal condition of elevated bilirubin in the bloodstream of a newborn. This occurs secondary to immaturity of liver cells (cannot effectively metabolise bilirubin) and the increased destruction of red blood cells (further releasing bilirubin into the bloodstream) that is normally seen in the newborn. The jaundice usually appears between the 2nd and 5th days of life and usually clears by 2 weeks. Other factors which can potentiate jaundice in the newborn include: sepsis, biliary atresia, Rhesus incompatibility, galactosaemia, cephalohaematoma, polycythaemia, G-6-P-D deficiency and congenital rubella, syphilis, toxoplasmosis or cytomegalovirus infection. (10 Jan 1998) |
| newborn screening | Tests of newborns to detect those at increased risk for disorders such as pku (phenylketonuria) and hypothyroidism. (12 Dec 1998) |
| subcutaneous fat necrosis of newborn | Indurated plaques and nodules appearing usually a few days or a few weeks after birth and usually resolving within a few months, characterised microscopically by birefringent needle-shaped crystals within necrotic fat cells; the condition remains localised, unlike sclerema neonatorum. (05 Mar 2000) |
| disease, haemolytic, of the newborn | Abnormal breakup of red blood cells in the foetus or newborn. (12 Dec 1998) |
| infant, newborn | An infant during the first month after birth. (12 Dec 1998) |
| infant, newborn, diseases | Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both hereditary diseases and metabolism, inborn errors are available as general concepts. (12 Dec 1998) |
| jaundice of the newborn | Icterus which can be accentuated by many factors including excessive haemolysis, sepsis, neonatal hepatitis or congenital atresia of the biliary system. Synonym: physiologic icterus, jaundice of the newborn, neonatal jaundice, physiologic jaundice. (05 Mar 2000) |
| leukocytosis of the newborn | An apparently "physiologic" leukocytosis usually observed in newborn infants, in whom the white blood cell counts are usually greater than 10,000 per cu mm, and sometimes range to 45,000 per cu mm, resulting chiefly from increased numbers of neutrophils (especially single and bilobed forms). On the third or fourth day of life, the count generally decreases rapidly, and then fluctuates for several days; beginning about the fourth week of life, a relative lymphocytosis is observed, and this normally continues for a few years. (05 Mar 2000) |
| abortion, multiple | Couples who have had 2 or more miscarriages (spontaneous abortions) have about a 5% chance that one member of the couple is carrying a chromsome translocation responsible for the miscarriages. (12 Dec 1998) |
| advanced multiple-beam equalization radiography | A variant of scanning equalization radiography using several X-ray beams. (05 Mar 2000) |
| amyloidosis of multiple myeloma | Foci of amyloidosis in mesenchymal tissues of some persons with multiple myeloma; no direct relation between amyloid and Bence Jones protein is conclusively known. (05 Mar 2000) |
| cancer, multiple myeloma | A bone marrow cancer involving a type of white blood cell called a plasma (or myeloma) cell. The tumour cells can form a single collection (a plasmacytoma) or many tumours (multiple myeloma). Plasma cells are part of the immune system and make antibodies. Because patients have an excess of identical plasma cells, they have too much of one type of antibody. As myeloma cells increase in number, they damage and weaken the bones, causing pain and often fractures. When bones are damaged, calcium is released into the blood leading to hypercalcaemia (excess calcium in the blood) and that causes loss of appetite, nausea, thirst, fatigue, muscle weakness, restlessness, and confusion. Myeloma cells prevent the bone marrow from forming normal plasma cells and other white blood cells important to the immune system so patients may not be able to fight infections. The cancer cells can also prevent the growth of new red blood cells, causing anaemia. Excess antibody proteins and calcium may prevent the kidneys from filtering and cleaning the blood properly Cancer, non-Hodgkin's lymphoma: A lymphoma is a cancer that develops in the lymphatic system. The most common symptom of non-Hodgkin's lymphomas is a painless swelling in the lymph nodes in the neck, underarm, or groin. Non-Hodgkin's lymphomas are diagnosed with a biopsy of an enlarged lymph node. Follow-up examinations are important after lymphoma treatment. Most relapses occur in the first 2 years after therapy. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|